US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Insight Molecular Diagnostics Inc.

7.32

+0.63009.42%

Post-market: 7.320.00000.00%16:10 EST

Volume:61.50K

Turnover:434.28K

Market Cap:209.82M

PE:-3.23

High:7.48

Open:6.73

Low:6.54

Close:6.69

52wk High:8.51

52wk Low:1.95

Shares:28.66M

Float Shares:7.78M

Volume Ratio:3.71

T/O Rate:0.79%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.2672

EPS(LYR):-4.6612

ROE:-23603.11%

ROA:-28.44%

PB:-22.82

PE(LYR):-1.57

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Insight Molecular Diagnostics Unveils Decentralized dd-cfDNA Test for Transplant Monitoring

Insight Molecular Diagnostics Inc. Joins JPM Week and BTIG Snowbird Investor Conferences

Insight Molecular Diagnostics Appoints Dr. Nick Ioannou as Vice President of Medical Affairs

Press Release: iMDx to Welcome Industry Veteran as Vice President of Medical Affairs to Prepare for Commercial Transplant Assay Launch

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/IMDX"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IMDX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMDX\",,,,,undefined,":{"symbol":"IMDX","market":"US","secType":"STK","nameCN":"Insight Molecular Diagnostics Inc.","latestPrice":7.32,"timestamp":1770411600000,"preClose":6.69,"halted":0,"volume":61495,"hourTrading":{"tag":"盘后","latestPrice":7.32,"preClose":7.32,"latestTime":"16:10 EST","volume":7,"amount":51.24,"timestamp":1770412204845,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.09417040358744393,"floatShares":7775507,"shares":28664437,"eps":-2.267159,"marketStatus":"Market Closed","change":0.63,"latestTime":"02-06 16:00:00 EST","open":6.73,"high":7.48,"low":6.54,"amount":434275.7681,"amplitude":0.140508,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.267159,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":6.69,"preHourTrading":{"tag":"盘前","latestPrice":6.68,"preClose":6.69,"latestTime":"08:00 EST","volume":18,"amount":120.24,"timestamp":1770382800807,"change":-0.01,"changeRate":-0.001495,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":7.32,"preClose":7.32,"latestTime":"16:10 EST","volume":7,"amount":51.24,"timestamp":1770412204845,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":3.705232,"impliedVol":1.5676,"impliedVolPercentile":0.7458},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMDX\",,,,,undefined,":{"symbol":"IMDX","floatShares":7775507,"roa":"-28.44%","roe":"-23603.11%","lyrEps":-4.661158,"volumeRatio":3.705232,"shares":28664437,"dividePrice":0,"high":7.48,"amplitude":0.140508,"preClose":6.69,"low":6.54,"week52Low":1.945,"pbRate":"-22.82","psRate":"47.67","week52High":8.51,"institutionHeld":0,"latestPrice":7.32,"eps":-2.267159,"divideRate":0,"volume":61495,"delay":0,"ttmEps":-2.267159,"open":6.73,"prevYearClose":7.5,"prevWeekClose":6.52,"prevMonthClose":6.52,"prevQuarterClose":7.5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMDX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-10","symbol":"IMDX","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"post","actualEps":-0.34},{"market":"US","date":"2025-08-11","symbol":"IMDX","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"post","actualEps":-0.3},{"market":"US","date":"2025-05-12","symbol":"IMDX","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"post","actualEps":-0.26},{"market":"US","date":"2025-03-24","symbol":"IMDX","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742788800000,"reportTimeType":"post","actualEps":0.48},{"market":"US","date":"2024-11-12","symbol":"IMDX","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-0.98}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMDX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IMDX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.5,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":4,"updateTime":1743138000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IMDX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IMDX","date":"2026-02-05","current":-3.22871,"percent":0.139241,"low":-3.993147,"twenty":-3.004801,"median":-1.798357,"eighty":-1.36397,"high":-1.083107,"avg":-2.141293,"sd":0.829126,"marketCap":190331861},"quantilePoints":[{"date":"2025-06-20","current":-1.55268,"twenty":-1.55268,"median":-1.55268,"eighty":-1.55268,"marketCap":90373740},{"date":"2025-06-27","current":-1.655864,"twenty":-1.798357,"median":-1.675518,"eighty":-1.638667,"marketCap":96379590},{"date":"2025-07-03","current":-1.40036,"twenty":-1.71581,"median":-1.6055,"eighty":-1.491752,"marketCap":81507962},{"date":"2025-07-11","current":-1.420014,"twenty":-1.663726,"median":-1.493717,"eighty":-1.427876,"marketCap":82651933},{"date":"2025-07-18","current":-1.390533,"twenty":-1.642106,"median":-1.471607,"eighty":-1.399377,"marketCap":80935976},{"date":"2025-07-25","current":-1.454409,"twenty":-1.585601,"median":-1.459323,"eighty":-1.399377,"marketCap":84653883},{"date":"2025-08-01","current":-1.238213,"twenty":-1.556611,"median":-1.424927,"eighty":-1.390533,"marketCap":72070198},{"date":"2025-08-08","current":-1.289805,"twenty":-1.50551,"median":-1.405274,"eighty":-1.357121,"marketCap":75073123},{"date":"2025-08-15","current":-1.083107,"twenty":-1.489787,"median":-1.40036,"eighty":-1.288331,"marketCap":68687397},{"date":"2025-08-22","current":-1.119211,"twenty":-1.488804,"median":-1.395447,"eighty":-1.253936,"marketCap":70976977},{"date":"2025-08-29","current":-1.132749,"twenty":-1.484873,"median":-1.380706,"eighty":-1.161632,"marketCap":71835569},{"date":"2025-09-05","current":-1.114698,"twenty":-1.480942,"median":-1.363484,"eighty":-1.138165,"marketCap":70690780},{"date":"2025-09-12","current":-1.435117,"twenty":-1.467185,"median":-1.353884,"eighty":-1.132749,"marketCap":91010801},{"date":"2025-09-19","current":-1.520863,"twenty":-1.485856,"median":-1.368397,"eighty":-1.138165,"marketCap":96448554},{"date":"2025-09-26","current":-1.47122,"twenty":-1.485856,"median":-1.389987,"eighty":-1.149898,"marketCap":93300381},{"date":"2025-10-03","current":-1.507324,"twenty":-1.490769,"median":-1.392517,"eighty":-1.163437,"marketCap":95589961},{"date":"2025-10-10","current":-1.714919,"twenty":-1.500103,"median":-1.395447,"eighty":-1.171561,"marketCap":108755046},{"date":"2025-10-17","current":-2.087237,"twenty":-1.528084,"median":-1.402817,"eighty":-1.173366,"marketCap":132366339},{"date":"2025-10-24","current":-2.897311,"twenty":-1.598867,"median":-1.417558,"eighty":-1.192321,"marketCap":183738788},{"date":"2025-10-31","current":-2.67392,"twenty":-1.674528,"median":-1.432479,"eighty":-1.204957,"marketCap":169572012},{"date":"2025-11-07","current":-2.933415,"twenty":-1.775372,"median":-1.457682,"eighty":-1.224911,"marketCap":186028368},{"date":"2025-11-14","current":-3.696486,"twenty":-2.084901,"median":-1.473476,"eighty":-1.250005,"marketCap":224665029},{"date":"2025-11-21","current":-2.862765,"twenty":-2.669859,"median":-1.478977,"eighty":-1.260815,"marketCap":173993132},{"date":"2025-11-28","current":-2.895779,"twenty":-2.764631,"median":-1.48389,"eighty":-1.270643,"marketCap":175999643},{"date":"2025-12-05","current":-2.631669,"twenty":-2.764631,"median":-1.488804,"eighty":-1.282435,"marketCap":159947558},{"date":"2025-12-12","current":-2.452451,"twenty":-2.743778,"median":-1.493785,"eighty":-1.285383,"marketCap":149055072},{"date":"2025-12-19","current":-2.447735,"twenty":-2.714849,"median":-1.505068,"eighty":-1.294719,"marketCap":148768428},{"date":"2025-12-26","current":-2.744859,"twenty":-2.739199,"median":-1.51635,"eighty":-1.307003,"marketCap":166827023},{"date":"2026-01-02","current":-3.537189,"twenty":-2.766436,"median":-1.545684,"eighty":-1.326657,"marketCap":214983277},{"date":"2026-01-09","current":-3.537189,"twenty":-2.848616,"median":-1.572334,"eighty":-1.341398,"marketCap":214983277},{"date":"2026-01-16","current":-3.122159,"twenty":-2.895779,"median":-1.658314,"eighty":-1.353884,"marketCap":189758572},{"date":"2026-01-23","current":-3.150456,"twenty":-2.900495,"median":-1.677968,"eighty":-1.357494,"marketCap":191478439},{"date":"2026-01-30","current":-3.122159,"twenty":-2.986727,"median":-1.755536,"eighty":-1.360521,"marketCap":189758572},{"date":"2026-02-05","current":-3.131591,"twenty":-3.004801,"median":-1.798357,"eighty":-1.36397,"marketCap":190331861}],"updateTime":1770441437855},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IMDX\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2603868719","title":"Insight Molecular Diagnostics Unveils Decentralized dd-cfDNA Test for Transplant Monitoring","url":"https://stock-news.laohu8.com/highlight/detail?id=2603868719","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603868719?lang=en_us&edition=fundamental","pubTime":"2026-01-13 22:00","pubTimestamp":1768312851,"startTime":"0","endTime":"0","summary":"Insight Molecular Diagnostics Inc.  announced support for the STAR working group’s recent position paper in the American Journal of Transplantation, which calls for decentralized donor-derived cell-free DNA  testing in transplant monitoring. The paper highlights the importance of high-quality, standardized decentralized testing and the diagnostic value of absolute quantification of dd-cfDNA—a key feature of IMDX’s GraftAssure family of assays. IMDX’s technology, developed by its scientists in Germany and the U.S., is commercially available through its GraftAssureCore laboratory-developed test and the GraftAssureIQ research-use-only kit. The company is pursuing decentralization of transplant rejection testing, aiming to improve patient care and hospital sustainability in a growing market. The research results referenced are detailed in the recently published position paper.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUB","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nNDL1rBfRM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","LU2095319765.USD","SG9999014013.SGD","LU0314104364.USD","BK4139","LU2210150020.SGD","SG9999014039.USD","IE00B3QW5Z07.USD","BK4112","LU2210149790.SGD","SG9999014021.USD","IMDX","NDAQ","BK4588","SG9999014005.SGD","IE00B64PRP62.GBP","BK4585","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2601389344","title":"Insight Molecular Diagnostics Inc. Joins JPM Week and BTIG Snowbird Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2601389344","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601389344?lang=en_us&edition=fundamental","pubTime":"2026-01-08 05:05","pubTimestamp":1767819951,"startTime":"0","endTime":"0","summary":"Insight Molecular Diagnostics Inc.  will participate in several investor conferences this winter. The company’s management team will hold one-on-one meetings at the LifeSci Advisors 15th Annual Corporate Access Event on January 12 in San Francisco, as well as additional investor meetings in San Francisco from January 12 to January 14 during \"JPM Week.\" iMDx will also attend the BTIG 13th Annual Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference, taking place from February 9 to 11 at Cliff Lodge in Snowbird, Utah.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insight Molecular Diagnostics Inc. published the original content used to generate this news brief via GlobeNewswire  on January 07, 2026, and is solel","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nNDL6fzSNp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMDX","SG9999014021.USD","LU2210149790.SGD","BK4585","SG9999014013.SGD","SG9999014005.SGD","BK4082","SG9999014039.USD","BK4139","NDAQ","MDIT","BK4112","IE00B3QW5Z07.USD","LU2095319765.USD","IE00B64PRP62.GBP","LU0314104364.USD","LU2210150020.SGD","IE00BKPKM429.USD","BK4588","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2601089765","title":"Insight Molecular Diagnostics Appoints Dr. Nick Ioannou as Vice President of Medical Affairs","url":"https://stock-news.laohu8.com/highlight/detail?id=2601089765","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601089765?lang=en_us&edition=fundamental","pubTime":"2026-01-06 21:01","pubTimestamp":1767704509,"startTime":"0","endTime":"0","summary":"Insight Molecular Diagnostics Inc. has appointed Dr. Nick Ioannou as Vice President of Medical Affairs. Dr. Ioannou brings over thirty years of experience in clinical practice, diagnostics, and medical affairs, with a focus on organ transplantation, nephrology, cardiology, genetics, and oncology. He joins the company as it prepares to launch its first commercial transplant assay.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insight Molecular Diagnostics Inc. published the original content used to generate this news brief via GlobeNewswire  on January 06, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nNDL5bNQhK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","IE00BKPKM429.USD","MDIT","LU2210149790.SGD","LU2095319765.USD","BK4139","LU0314104364.USD","IMDX","SG9999014021.USD","BK4585","BK4082","IE00BGHQF748.EUR","NDAQ","SG9999014039.USD","SG9999014013.SGD","BK4112","IE00B64PRP62.GBP","LU2210150020.SGD","BK4588","SG9999014005.SGD"],"gpt_icon":0},{"id":"2601507897","title":"Press Release: iMDx to Welcome Industry Veteran as Vice President of Medical Affairs to Prepare for Commercial Transplant Assay Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2601507897","media":"Dow Jones","labels":["executive","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601507897?lang=en_us&edition=fundamental","pubTime":"2026-01-06 21:01","pubTimestamp":1767704460,"startTime":"0","endTime":"0","summary":"-- Dr. Nick Ioannou brings decades of academia, industry, and clinical. experience in organ transplant, nephrology, cardiology, genetics, and. Dr. Ioannou is a physician-scientist with more than three decades of highly relevant experience spanning clinical practice, diagnostics, regulatory affairs, medical education, and medical affairs. His background includes over fifteen years of field-based collaboration with key opinion leaders across multiple therapeutic areas, particularly in organ transplantation, nephrology, cardiology, pulmonology, genetics, and oncology.Dr. Ioannou received a Bachelor of Science in Microbiology from California State University, Northridge, a Master of Healthcare Administration from Saint Joseph's College of Maine and completed his Medical Doctorate clinical training at Michael Reese Hospital in Chic","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03160","BK4555","IMDX","BK4099","BK4604","BK4585","BK4588","BK4139","TM"],"gpt_icon":0}],"pageSize":4,"totalPage":8,"pageCount":1,"totalSize":31,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/IMDX\",params:#limit:6,delay:false,,,undefined,":[]}}